Compare Enphase Energy Inc (ENPH) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enphase Energy Inc vs GeneDx Holdings Corp — how do they compare? Enphase Energy Inc trades at $32.7 (market cap $4.35B), while GeneDx Holdings Corp trades at $67.29 (market cap $2.02B). The key difference: Enphase Energy Inc is far larger — about 2.2× GeneDx Holdings Corp's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, Enphase Energy Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enphase Energy Inc for 72 Days and GeneDx Holdings Corp for 19 Days on average.
| ENPH | WGS | |
|---|---|---|
Market Cap | $4.35B | $2.02B |
Volume | 5,068,595 | 734,640 |
Sector | Energy | Health |
52-Week High | $72.33 | $167.51 |
52-Week Low | $26.12 | $34.51 |
Typical Hold Time | 72 Days | 19 Days |
Enterprise Value | $3.99B | $2.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enphase Energy (ENPH) trades at $32.81, down 2.06% on the day, with a bearish technical signal from moving averages and mixed recent earnings. The company reported revenue of $1.47B and net income of $172.13M for 2025, with a P/E ratio of 32.58. Recent news highlights product approvals and manufacturing milestones for AI data center power solutions, though the solar sector faces headwinds from high borrowing costs.
The outlook is cautious; while analyst consensus is a Buy with a $42.90 price target, near-term risks include sector volatility and recent earnings misses. Long-term opportunities hinge on execution in the energy technology and AI infrastructure markets, but investors should weigh competitive pressures and macroeconomic factors affecting solar project financing.
GeneDx (WGS) trades at $68.09, down 0.64% today, with a bearish technical signal despite bullish oscillators showing oversold conditions. The company reported mixed Q2 2026 results with revenue beating expectations but negative profitability metrics, including a -23.4% net income margin. Recent news highlights product launches and industry recognition, while analyst consensus remains strongly bullish with a $81 price target.
The stock presents a growth opportunity in genomic testing with strong analyst support, but faces significant execution risks from persistent losses and high valuation multiples. Key catalysts include continued revenue growth and path to profitability, while risks include competitive pressures and cash flow challenges from negative operating cash flow in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enphase Energy Inc
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
Read more on ENPH →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
